Acute Lung Injury Market to Grow at a CAGR of 4.7% to reach US$ 741.98 million from 2021 to 2028

    Acute Lung Injury Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy (Mechanical Ventilation, Fluid Management, Pharmacotherapy, and Adjunctive Procedures) and End User (Hospitals, Ambulatory Surgery Centers, and Others) and Geography

    Publication Month: Sep 2021 | Report Code: TIPRE00015798 | No. of Pages: 141 | Category: Pharmaceuticals | Status: Published

    The acute lung injury market is projected to reach US$ 741.98 million by 2028 from US$ 539.61 million in 2021; it is expected to register a CAGR of 4.7% from 2021 to 2028.

    Acute lung injury (ALI) is a life-threatening condition in critically unhealthy patients. In acute lung injury disorder, acute inflammation occurs in the lung, which leads to the disruption of the lung endothelial and epithelial barriers. The alveolar-capillary membrane is composed of the microvascular endothelium, interstitium, and alveolar epithelium. Acute Lung Injury Market is diagnosed clinically based on the appearance of non-cardiogenic pulmonary odema and respiratory failure in a critically ill patient. Its incidence is normal; it is likely to exist outside the intensive care setting and therefore is a condition relevant to all clinicians.

    The report offers insights and in-depth analysis of the acute lung injury market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players worldwide. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. Presently, the US is the world's worst-affected country due to the COVID-19 outbreak with the highest number of confirmed cases and deaths, as per the recent WHO statistics. The high number of COVID cases has negatively impacted the country's and region's economies. There has been a decline in overall business activities and growth of various industries operating in the region.

    However, acute lung injury market players are initiating clinical trials to develop drugs to treat acute lung injury. For instance, Chimerix, a biopharmaceutical company, initiated a Phase II/III clinical trial in June 2020 to evaluate the safety and efficacy of Dociparstat sodium (DSTAT) in patients with acute lung injury (ALI) due to COVID-19. Furthermore, Altasciences is pleased to support ReAlta Life Sciences by conducting a Phase I trial to evaluate RLS-0071 for acute lung injury (ALI) as a result of viral infections such as COVID-19, respiratory syncytial virus (RSV), and influenza. COVID-19-related issues have propelled the acute lung injury market growth in the region.

    Based on region, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

    Lucrative Regions for Acute lung injury Market

    Lucrative Regions for Acute lung injury Market

    Get more information on this report :



    Market Insights

    Increasing Prevalence of Respiratory Diseases Drives Acute Lung Injury Market

    The high prevalence of respiratory conditions is associated with the decrease in the size of the upper airway lumen in the aging population. Lung disorders are among the most common medical conditions across the world. According to the Centers for Disease Control and Prevention (CDC), lung diseases such as chronic obstructive pulmonary disease (COPD) and acute lung injury (ALI) are the third leading cause of death in the US. People worldwide suffer from various sorts of respiratory diseases. Smoking, infections, and genetic factors are among the common factors responsible for respiratory disorders. Medical conditions such as COPD, asthma, chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens.

    Patients suffering from these respiratory disorders commonly experience difficulty in breathing. The respiratory failure associated with acute lung injury or the acute respiratory distress syndrome (ARDS) is one of the most critical contributors to postoperative mortality.

    Moreover, the CDC, the US Food and Drug Administration (FDA), state and local health departments, and other clinical and public health associates continue to monitor smoking e-cigarette or vaping product use associated lung injury (EVALI). According to the CDC, a total of 2,807 hospitalized EVALI cases or deaths from all 50 states, the District of Columbia, and two US territories (Puerto Rico and US Virgin Islands) have been recorded as of February 2020. Thus, all the factors mentioned above are expected to result in the growth of the acute lung injury market during the forecast period.

    Therapy-Based Insights

    Based on therapy, the acute lung injury market is segmented into mechanical ventilation, fluid management, pharmacotherapy, and adjunctive procedures. In 2021, the mechanical ventilation segment accounted for the largest market share in the global acute lung injury market. The segment's growth is attributed to the fact that mechanical ventilation in acute lung injury (ALI) aims to maintain oxygen while avoiding its toxicity and complications associated with the ventilation.

    Acute lung injury Market, by Therapy – 2020 and 2028

    Acute lung injury Market, by Therapy – 2020 and 2028

    Get more information on this report :



    End User-Based Insights

    Based on end user, the acute lung injury market is segmented into hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 4.9% of the market during the forecast period.

    Strategic Insights

    The acute lung injury market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand.

    By Therapy

    • Mechanical Ventilation
    • Fluid Management
    • Pharmacotherapy
    • Adjunctive Procedures

    By End User

    • Hospitals
    • Ambulatory Surgery Centers
    • Others

    By

    Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM


    Company Profiles

    • GlaxoSmithKline plc.
    • Stemedica Cell Technologies, Inc
    • Histocell
    • APEPTICO Forschung und Entwicklung GmbH
    • Windtree Therapeutics, Inc.
    • ReAlta Life Sciences, Inc.
    • Apeiron Biologics AG
    • Qx Therapeutics, Inc.
    • Angion
    • Asklepion Pharmaceuticals, LLC

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Acute Lung Injury Market – By Therapy

    1.3.2 Global Acute Lung Injury Market – By End User

    1.3.3 Global Acute Lung Injury Market– By Geography

    2. Global Acute Lung Injury Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Acute Lung Injury Market– Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe– PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Experts Opinion

    5. Acute Lung Injury Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Increasing Prevalence of Respiratory Diseases

    5.1.1 Rising Geriatric Population

    5.2 Market Restraints

    5.2.1 High Cost of Therapies

    5.3 Market Opportunities

    5.3.1 Technological Advancements by Market Players

    5.4 Future Trends

    5.4.1 Growing Pipeline Drugs

    5.5 Impact Analysis

    6. Acute Lung Injury Market– Global Analysis

    6.1 Global Acute Lung Injury Market Revenue Forecast and Analysis

    6.2 Global Acute Lung Injury Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Acute Lung Injury Market Analysis and Forecast to 2028 – By Therapy

    7.1 Overview

    7.2 Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

    7.3 Mechanical Ventilation

    7.3.1 Overview

    7.3.2 Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    7.4 Fluid Management

    7.4.1 Overview

    7.4.2 Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    7.5 Pharmacotherapy

    7.5.1 Overview

    7.5.2 Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    7.6 Adjunctive Procedures

    7.6.1 Overview

    7.6.2 Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    8. Acute Lung Injury Market Analysis – By End-User

    8.1 Overview

    8.2 Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

    8.3 Hospitals

    8.3.1 Overview

    8.3.2 Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    8.4 Ambulatory Surgery Centers

    8.4.1 Overview

    8.4.2 Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    8.5 Others

    8.5.1 Overview

    8.5.2 Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    9. Global Acute Lung Injury Market – Geographic Analysis

    9.1 North America: Acute Lung Injury Market

    9.1.1 Overview

    9.1.2 North America: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)

    9.1.3 North America Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.1.4 North America Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    9.1.5 North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    9.1.5.1 US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.1.1 US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.1.2 US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.1.5.1.3 US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    9.1.5.2 Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.2.1 Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.2.2 Canada Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.1.5.2.3 Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    9.1.5.3 Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.3.1 Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.1.5.3.2 Mexico Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.1.5.3.3 Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    9.2 Europe: Acute Lung Injury Market

    9.2.1 Overview

    9.2.2 Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.3 Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.4 Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5 Europe: Acute Lung Injury Market, by Country, 2021 & 2028(%)

    9.2.5.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.1.1 Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.1.2 Germany: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.1.3 Germany: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5.2 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.2.1 France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.2.2 France: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.2.3 France: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5.3 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.3.1 UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.3.2 UK: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.3.3 UK: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5.4 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.4.1 Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.4.2 Italy: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.4.3 Italy: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5.5 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.5.1 Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.5.2 Spain: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.5.3 Spain: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.2.5.6 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.6.1 Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.2.5.6.2 Rest of Europe: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.2.5.6.3 Rest of Europe: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3 Asia Pacific: Acute Lung Injury Market

    9.3.1 Overview

    9.3.2 Asia Pacific: Acute Lung Injury Market - Revenue and Forecast to 2028 (USD Million)

    9.3.3 Asia Pacific: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.4 Asia Pacific: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5 Asia Pacific: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    9.3.5.1 China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.1.1 China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.1.2 China: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.1.3 China: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5.2 Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.2.1 Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.2.2 Japan: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.2.3 Japan: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5.3 India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.3.1 India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.3.2 India: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.3.3 India: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5.4 South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.4.1 South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.4.2 South Korea: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.4.3 South Korea: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5.5 Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.5.1 Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.5.2 Australia: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.5.3 Australia: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.3.5.6 Rest of Asia Pacific: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.6.1 Rest of Asia Pacific: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.3.5.6.2 Rest of Asia Pacific: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    9.3.5.6.3 Rest of Asia Pacific: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.4 Middle East and Africa: Acute Lung Injury Market

    9.4.1 Overview

    9.4.2 Middle East and Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.3 Middle East and Africa: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.4.4 Middle East and Africa: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.4.5 Middle East and Africa: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    9.4.5.1 Saudi Arabia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.1.1 Saudi Arabia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.1.2 Saudi Arabia: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.4.5.1.3 Saudi Arabia: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.4.5.2 South Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.2.1 South Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.2.2 South Africa: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.4.5.2.3 South Africa: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.4.5.3 UAE: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.3.1 UAE: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.3.2 UAE: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.4.5.3.3 UAE: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.4.5.4 Rest of Middle East and Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.4.1 Rest of Middle East and Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.4.5.4.2 Rest of Middle East and Africa: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.4.5.4.3 Rest of Middle East and Africa: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.5 South and Central America: Acute Lung Injury Market

    9.5.1 Overview

    9.5.2 South and Central America: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.3 South and Central America: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.5.4 South and Central America: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.5.5 South and Central America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    9.5.5.1 Brazil: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.1.1 Brazil: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.1.2 Brazil: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.5.5.1.3 Brazil: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.5.5.2 Argentina: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.2.1 Argentina: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.2.2 Argentina: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.5.5.2.3 Argentina: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    9.5.5.3 Rest of South and Central America: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.3.1 Rest of South and Central America: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    9.5.5.3.2 Rest of South and Central America: Acute Lung Injury Market, by Therapy, 2019–2028 (USD Million)

    9.5.5.3.3 Rest of South and Central America: Acute Lung Injury Market, by End User, 2019–2028 (USD Million)

    10. Impact Of COVID-19 Pandemic on Acute Lung Injury Market

    10.1 North America: Impact Assessment of COVID-19 Pandemic

    10.2 Europe: Impact Assessment of COVID-19 Pandemic

    10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

    10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    11. Acute Lung Injury Market– Industry Landscape

    11.1 Overview

    11.2 Growth Strategies Done by the Companies in the Acute Lung Injury Market, (%)

    11.3 Organic Developments

    11.3.1 Overview

    11.4 Inorganic Developments

    11.4.1 Overview

    12. Company Profiles

    12.1 GlaxoSmithKline Plc

    12.1.1 Key Facts

    12.1.2 Business Description

    12.1.3 Products and Services

    12.1.4 Financial Overview

    12.1.5 SWOT Analysis

    12.1.6 Key Developments

    12.2 Stemedica Cell Technologies, Inc

    12.2.1 Key Facts

    12.2.2 Business Description

    12.2.3 Products and Services

    12.2.4 Financial Overview

    12.2.5 SWOT Analysis

    12.2.6 Key Developments

    12.3 Histocell

    12.3.1 Key Facts

    12.3.2 Business Description

    12.3.3 Products and Services

    12.3.4 Financial Overview

    12.3.5 SWOT Analysis

    12.3.6 Key Developments

    12.4 APEPTICO Forschung und Entwicklung GmbH

    12.4.1 Key Facts

    12.4.2 Business Description

    12.4.3 Products and Services

    12.4.4 Financial Overview

    12.4.5 SWOT Analysis

    12.4.6 Key Developments

    12.5 Windtree Therapeutics, Inc.

    12.5.1 Key Facts

    12.5.2 Business Description

    12.5.3 Products and Services

    12.5.4 Financial Overview

    12.5.5 SWOT Analysis

    12.5.6 Key Developments

    12.6 ReAlta Life Sciences, Inc.

    12.6.1 Key Facts

    12.6.2 Business Description

    12.6.3 Products and Services

    12.6.4 Financial Overview

    12.6.5 SWOT Analysis

    12.6.6 Key Developments

    12.7 Apeiron Biologics AG

    12.7.1 Key Facts

    12.7.2 Business Description

    12.7.3 Products and Services

    12.7.4 Financial Overview

    12.7.5 SWOT Analysis

    12.7.6 Key Developments

    12.8 Qx Therapeutics, Inc.

    12.8.1 Key Facts

    12.8.2 Business Description

    12.8.3 Products and Services

    12.8.4 Financial Overview

    12.8.5 SWOT Analysis

    12.8.6 Key Developments

    12.9 Angion

    12.9.1 Key Facts

    12.9.2 Business Description

    12.9.3 Products and Services

    12.9.4 Financial Overview

    12.9.5 SWOT Analysis

    12.9.6 Key Developments

    12.10 Asklepion Pharmaceuticals, LLC.

    12.10.1 Key Facts

    12.10.2 Business Description

    12.10.3 Products and Services

    12.10.4 Financial Overview

    12.10.5 SWOT Analysis

    12.10.6 Key Developments

    13. Appendix

    13.1 About The Insight Partners

    13.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 2. North America Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 3. US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 4. US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 5. Canada Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million)

    Table 6. Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 7. Mexico Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million)

    Table 8. Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million)

    Table 9. Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 10. Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 11. Germany: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 12. Germany: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 13. France: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 14. France: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 15. UK: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 16. UK: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 17. Italy: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 18. Italy: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 19. Spain: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 20. Spain: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 21. Rest of Europe: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 22. Rest of Europe: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 23. Asia Pacific: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 24. Asia Pacific: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 25. China: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

    Table 26. China: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 27. Japan: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

    Table 28. Japan: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 29. India: Acute Lung Injury Market, by Therapy– Revenue and Forecast to 2028 (USD Million)

    Table 30. India: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 31. South Korea: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 32. South Korea: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 33. Australia: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 34. Australia: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 35. Rest of Asia Pacific: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 36. Rest of Asia Pacific: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 37. Middle East and Africa: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 38. Middle East and Africa: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 39. Saudi Arabia: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 40. Saudi Arabia: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 41. South Africa: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 42. South Africa: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 43. UAE: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 44. UAE: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 45. Rest of Middle East and Africa: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 46. Rest of Middle East and Africa: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 47. South and Central America: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 48. South and Central America: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 49. Brazil: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 50. Brazil: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 51. Argentina: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 52. Argentina: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 53. Rest of South and Central America: Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million)

    Table 54. Rest of South and Central America: Acute Lung Injury Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 55. Organic Developments Done by Companies

    Table 56. Inorganic Developments Done by Companies

    Table 57. Glossary of Terms, Acute Lung Injury Market

    LIST OF FIGURES

    Figure 1. Acute Lung Injury Market Segmentation

    Figure 2. Acute Lung Injury Market Segmentation, By Region

    Figure 3. Global Acute Lung Injury Market Overview

    Figure 4. Mechanical Ventilation Segment Held the Largest Share by Therapy in Acute Lung Injury Market

    Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

    Figure 6. Acute Lung Injury Market, by Geography (US$ Million)

    Figure 7. Global Acute Lung Injury Market– Leading Country Markets (US$ Million)

    Figure 8. North America PEST Analysis

    Figure 9. Europe and PEST Analysis

    Figure 10. Asia Pacific PEST Analysis

    Figure 11. Middle East and Africa PEST Analysis

    Figure 12. South and Central America (SCAM) PEST Analysis

    Figure 13. Acute Lung Injury Market Impact Analysis of Driver and Restraints

    Figure 14. Global Acute Lung Injury Market– Revenue Forecast and Analysis – 2020- 2028

    Figure 15. Global Acute Lung Injury Market – By Geography Forecast and Analysis – 2021- 2028

    Figure 16. Market Positioning of Key Players in Global Acute Lung Injury Market

    Figure 17. Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028)

    Figure 18. Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 19. Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20. Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22. Acute Lung Injury Market Revenue Share, by End User (2021 and 2028)

    Figure 23. Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24. Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26. North America: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

    Figure 27. North America Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)

    Figure 28. North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    Figure 29. US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 30. Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 31. Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 32. Europe: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

    Figure 33. Europe: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)

    Figure 34. Europe: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    Figure 35. Germany: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 36. France: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 37. UK: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 38. Italy: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 39. Spain: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 40. Rest of Europe: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 41. Asia Pacific: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

    Figure 42. Asia Pacific: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)

    Figure 43. Asia Pacific: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    Figure 44. China: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 45. Japan: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 46. India: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 47. South Korea: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 48. Australia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 49. Rest of Asia Pacific: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 50. Middle East and Africa: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

    Figure 51. Middle East and Africa: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)

    Figure 52. Middle East and Africa: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    Figure 53. Saudi Arabia: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 54. South Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 55. UAE: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 56. Rest of Middle East and Africa: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 57. South and Central America: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million)

    Figure 58. South and Central America: Acute Lung Injury Market Revenue and Forecast to 2028 (USD Million)

    Figure 59. South and Central America: Acute Lung Injury Market, by Country, 2021 & 2028 (%)

    Figure 60. Brazil: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 61. Argentina: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 62. Rest of South and Central America: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million)

    Figure 63. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 64. Impact of COVID-19 Pandemic in European Country Markets

    Figure 65. Impact of COVID-19 Pandemic on Asia Pacific Country Markets

    Figure 66. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

    Figure 67. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

    Figure 68. Growth Strategies Done by the Companies in the Acute Lung Injury Market, (%)


    The List of Companies - Acute Lung Injury Market

    1. GlaxoSmithKline plc.
    2. Stemedica Cell Technologies, Inc
    3. Histocell
    4. APEPTICO Forschung und Entwicklung GmbH
    5. Windtree Therapeutics, Inc.
    6. ReAlta Life Sciences, Inc.
    7. Apeiron Biologics AG
    8. Qx Therapeutics, Inc.
    9. Angion
    10. Asklepion Pharmaceuticals, LLC
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the acute lung injury market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global acute lung injury market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPRE00015798
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Asia Pacific is expected to be the fastest growing region and potential market for acute lung injury. Asia Pacific is expected to expand at a high growth rate. The growth of the acute lung injury market in this region is primarily due to high prevalence of this disease, and the rise in healthcare awareness related to the disease diagnosis. Additionally, developing healthcare infrastructure and increasing investments to boost the manufacturing capacities are projected to drive the Asia Pacific acute lung injury market during the forecast period.
    The growth of the market is attributed to increasing prevalence of respiratory diseases, and rising geriatric population drive the market growth. However, high cost of therapies hampers the market growth.
    The acute lung injury market majorly consists of players like GlaxoSmithKline plc., Stemedica Cell Technologies, Inc, Histocell, APEPTICO Forschung und Entwicklung GmbH, Windtree Therapeutics, Inc., ReAlta Life Sciences, Inc., Apeiron Biologics AG, Qx Therapeutics, Inc., Angion, and Asklepion Pharmaceuticals, LLC. among others. Histocell and APEPTICO Forschung und Entwicklung GmbH are the top most two companies in the market.

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst